Evidence map›Paper›PMID 28698597›Full record

ArticleScientific reports2017

Selenoprotein MsrB1 promotes anti-inflammatory cytokine gene expression in macrophages and controls immune response in vivo.

Byung Cheon Lee, Sang-Goo Lee, Min-Kyung Choo, Ji Hyung Kim, Hae Min Lee, Sorah Kim, Dmitri E Fomenko, Hwa-Young Kim, Jin Mo Park, Vadim N Gladyshev

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Effects and Impact of Selenium on Human Health, A Review.Molecules (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Selenoproteins in Health.Molecules (Basel, Switzerland) · 2023
    Review
  16. Review
  17. "Alphabet" Selenoproteins: Their Characteristics and Physiological Roles.International journal of molecular sciences · 2023
    Review
  18. Article
  19. Biological and Catalytic Properties of Selenoproteins.International journal of molecular sciences · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Byung Cheon LeeCollege of Life Sciences and Biotechnology, Korea University, Seoul, 02841, South Korea. cheonii@korea.ac.kr.
Sang-Goo LeeDivision of Genetics, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
Min-Kyung ChooCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, 02129, USA.
Ji Hyung KimProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02115, USA.
Hae Min LeeCollege of Life Sciences and Biotechnology, Korea University, Seoul, 02841, South Korea.
Sorah KimCollege of Life Sciences and Biotechnology, Korea University, Seoul, 02841, South Korea.
Dmitri E FomenkoDepartment of Biochemistry and Redox Biology Center, University of Nebraska, Lincoln, NE, 68588, USA.
Hwa-Young KimDepartment of Biochemistry and Molecular Biology, Yeungnam University College of Medicine, Daegu, 42415, South Korea.
Jin Mo ParkCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, 02129, USA.ORCID 0000-0002-3458-5583
Vadim N GladyshevDivision of Genetics, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA. vgladyshev@rics.bwh.harvard.edu.
Korea University · KRBrigham and Women's Hospital · USHarvard University · USBoston Children's Hospital · USUniversity of Nebraska–Lincoln · USYeungnam University College

Funding

DERMATOLOGY TRAINING GRANTT32AR007098 · NIAMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI THOMAS S. KUPPER · 1986 to 2026
$8.1M
Methionine sulfoxide reduction, selenium and agingR01AG021518 · NIA · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2003 to 2018
$5.0M
NIAMS NIH HHS T32 AR007098NIA NIH HHS R01 AG021518
6 · The paper itself

Abstract

Post-translational redox modification of methionine residues often triggers a change in protein function. Emerging evidence points to this reversible protein modification being an important regulatory mechanism under various physiological conditions. Reduction of oxidized methionine residues is catalyzed by methionine sulfoxide reductases (Msrs). Here, we show that one of these enzymes, a selenium-containing MsrB1, is highly expressed in immune-activated macrophages and contributes to shaping cellular and organismal immune responses. In particular, lipopolysaccharide (LPS) induces expression of MsrB1, but not other Msrs. Genetic ablation of MsrB1 did not preclude LPS-induced intracellular signaling in macrophages, but resulted in attenuated induction of anti-inflammatory cytokines, such as interleukin (IL)-10 and the IL-1 receptor antagonist. This anomaly was associated with excessive pro-inflammatory cytokine production as well as an increase in acute tissue inflammation in mice. Together, our findings suggest that MsrB1 controls immune responses by promoting anti-inflammatory cytokine expression in macrophages. MsrB1-dependent reduction of oxidized methionine in proteins may be a heretofore unrecognized regulatory event underlying immunity and inflammatory disease, and a novel target for clinical applications.

Indexed as

AnimalsCells, CulturedFemaleGene Expression RegulationInterleukin-10Interleukin 1 Receptor Antagonist ProteinLipopolysaccharidesMacrophagesMethionine Sulfoxide ReductasesMicePhorbol EstersSignal TransductionUp-Regulation12-O-undecadienoylphorbol-13-acetateIL10 protein, mouseIL1RN protein, humanInterleukin-10Interleukin 1 Receptor Antagonist ProteinLipopolysaccharidesMethionine Sulfoxide ReductasesMsrB1 protein, mousePhorbol Esters

Identifiers

PMID28698597
PMCPMC5506048
OpenAlexW2730735968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.